Cardiovascular cell therapy and endogenous repair

Area of Science:

• Regenerative Medicine
• Cardiology
• Biotechnology

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality globally, with acute myocardial infarction (AMI) affecting approximately one million individuals annually in the USA.
• Rising CVD risk factors contribute to increased incidence in younger populations, leading to a higher prevalence of heart failure (HF) post-AMI.
• Current therapies improve survival post-AMI but increase HF incidence, necessitating novel interventions to prevent atherosclerosis, post-AMI HF, and progressive cardiac dysfunction.

Purpose of the Study:

• To explore the potential of cell therapy in addressing the unmet needs in cardiovascular disease management.
• To investigate cell-based strategies for preventing or reversing atherosclerosis, mitigating post-AMI heart failure, and halting cardiac functional decline.
• To review the application of exogenous cell delivery and endogenous cell mobilization for cardiac repair.

Main Methods:

• Review of existing literature on cell therapy applications in cardiovascular disease.
• Analysis of preclinical studies utilizing bone marrow-derived cells, blood-derived cells, and skeletal myoblasts for cardiac repair post-AMI.
• Examination of research focused on bone marrow precursors for atherosclerosis management and cell-based bioartificial constructs for myocardial replacement.

Main Results:

• Bone marrow- or blood-derived cells have shown promise in preventing left ventricular dysfunction after AMI.
• Skeletal myoblast transplantation has been explored in failing myocardium.
• Preclinical research is advancing towards using bone marrow precursors for atherosclerosis and developing cell-based constructs for heart regeneration.

Conclusions:

• Cell therapy, through exogenous delivery or endogenous mobilization, holds significant potential for improving the body's repair capacity in cardiovascular disease.
• Further research and development in cell-based strategies are crucial for preventing and reversing atherosclerosis, managing heart failure post-AMI, and ultimately regenerating cardiac tissue.
• Cell therapy represents a promising frontier in tackling the growing burden of cardiovascular disease and its complications.